EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Confined B‐Cell Reconstruction and High T‐Cell Clonality Define Clinical Response to Cladribine Treatment

Tilman Schneider-Hohendorf iD, Maria Eveslage, Timo Wirth, Christian Wünsch, Eva M Schumann, Jan D Lünemann iD, Heinz Wiendl, Luisa Klotz, Nicholas Schwab iD

Annals of Neurology · 2026

DOI: 10.1002/ana.78165 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Annals of Neurology, 2026. Verfasst von Tilman Schneider-Hohendorf und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, University Hospital Münster, Münster, Germany. Hauptthemen laut MEDLINE: Cladribine, Immunosuppressive Agents, B-Lymphocytes, T-Lymphocytes. Die Arbeit nennt 19 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Cladribine tablets are approved for relapsing multiple sclerosis, mediating their clinical effect by moderately depleting lymphocytes. In a prospective, monocentric study including 22 patients completing 2 annual cycles of cladribine, B‐ and T‐cell receptor repertoires and relapse activity were assessed at baseline and after 24 months. T‐cell clonality increased, driven by loss of low‐frequency, naive clonotypes, and re‐expansion of dominant CD8 memory clonotypes, particularly in clinically stable patients. In contrast, B‐cell receptor richness increased because of reconstruction by transitional and naive B cells with higher clonotype numbers observed in relapsing patients. Therefore, competing immune reconstitution following cladribine therapy could result in differential clinical responses. ANN NEUROL 2026

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

CladribineImmunosuppressive AgentsB-LymphocytesT-LymphocytesMultiple Sclerosis, Relapsing-RemittingHumansFemaleMaleAdultProspective StudiesTreatment OutcomeMiddle Aged

Substanzen

CladribineImmunosuppressive Agents

Autor:innen und Institutionen

  • Department of Neurology, University Hospital Münster, Münster, Germany.
  • Institute of Biostatistics and Clinical Research, University of Münster, Münster, Germany.
  • Department of Neurology and Neurophysiology, Medical Center, University of Freiburg, Freiburg, Germany.

ORCID-Profile: Tilman Schneider-Hohendorf, Jan D Lünemann, Nicholas Schwab

Zitieren

APA

Schneider-Hohendorf, T., Eveslage, M., Wirth, T., Wünsch, C., Schumann, E. M., Lünemann, J. D., Wiendl, H., Klotz, L., & Schwab, N. (2026). Confined B‐Cell Reconstruction and High T‐Cell Clonality Define Clinical Response to Cladribine Treatment. Annals of Neurology. https://doi.org/10.1002/ana.78165

Vancouver

Schneider-Hohendorf T, Eveslage M, Wirth T, Wünsch C, Schumann EM, Lünemann JD, et al. Confined B‐Cell Reconstruction and High T‐Cell Clonality Define Clinical Response to Cladribine Treatment. Annals of Neurology. 2026. doi:10.1002/ana.78165

BibTeX
@article{SchneiderHohendorf2026,
  author = {Schneider-Hohendorf, Tilman and Eveslage, Maria and Wirth, Timo and Wünsch, Christian and Schumann, Eva M and Lünemann, Jan D and Wiendl, Heinz and Klotz, Luisa and Schwab, Nicholas},
  title = {Confined B‐Cell Reconstruction and High T‐Cell Clonality Define Clinical Response to Cladribine Treatment},
  journal = {Annals of Neurology},
  year = {2026},
  doi = {10.1002/ana.78165}
}
Kostenlos starten →